Market Cap : 14.38 B | Enterprise Value : 14.51 B | P/E (TTM) : | P/B : 4.67 |
---|
NAS:BMRN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2019-12-09), Biomarin Pharmaceutical's share price is $80.08. Biomarin Pharmaceutical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.59. Hence, Biomarin Pharmaceutical's Price-to-Free-Cash-Flow Ratio for today is .
Biomarin Pharmaceutical's Free Cash Flow per Share for the three months ended in Sep. 2019 was $0.19. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.59.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 36.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 4.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -27.60% per year.
During the past 13 years, Biomarin Pharmaceutical's highest 3-Year average Free Cash Flow per Share Growth Rate was 71.50% per year. The lowest was -131.90% per year. And the median was 2.65% per year.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Biomarin Pharmaceutical's Price-to-Free-Cash-Flow falls into.
Biomarin Pharmaceutical's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 80.08 | / | -0.591 | |
= |
Biomarin Pharmaceutical's Share Price of today is $80.08.
Biomarin Pharmaceutical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2019 was 0.041 (Dec. 2018 ) + -0.469 (Mar. 2019 ) + -0.35 (Jun. 2019 ) + 0.187 (Sep. 2019 ) = $-0.59.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
No Headline